跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 325 条关于
“ESBL Klebsiella”
全部
325
临床试验
219
药物
32
机构
1
资讯
73
9天前
Brandi Glanville Details Multidrug-Resistant Infection and Fungal Ball Diagnosis Ahead of Surgery
去年
FDA Approves Iterum's ORLYNVAH for Uncomplicated Urinary Tract Infections
去年
FDA Approves Orlynvah, a New Oral Penem Antibiotic, for Uncomplicated UTIs
去年
Oral Sulopenem Shows Non-Inferiority to Standard Care in Phase 3 Trial for Uncomplicated UTIs
去年
FDA Approves ORLYNVAH™: First New Oral Treatment for Uncomplicated UTIs in 25 Years
7个月前
Iterum Therapeutics Expands ORLYNVAH Market Access While FDA Requires Additional Clinical Trial for Step-Down Therapy
去年
FDA Approves Iterum's Oral Penem ORLYNVAH™ for Uncomplicated Urinary Tract Infections
去年
Iterum Therapeutics Appoints Christine Coyne as Chief Commercial Officer to Lead ORLYNVAH Launch
去年
FDA Approves Orlynvah for Uncomplicated Urinary Tract Infections in Women with Limited Oral Antibiotic Options
4年前
Oral Carbapenems Face Regulatory Hurdles Despite Promise in Treating Multidrug-Resistant UTIs
第 1 页,共 8 页
上一页
下一页